Literature DB >> 21576246

The solution structure of heparan sulfate differs from that of heparin: implications for function.

Sanaullah Khan1, Elizabeth Rodriguez, Rima Patel, Jayesh Gor, Barbara Mulloy, Stephen J Perkins.   

Abstract

The highly sulfated polysaccharides heparin and heparan sulfate (HS) play key roles in the regulation of physiological and pathophysiological processes. Despite its importance, no molecular structures of free HS have been reported up to now. By combining analytical ultracentrifugation, small angle x-ray scattering, and constrained scattering modeling recently used for heparin, we have analyzed the solution structures for eight purified HS fragments degree of polymerization 6-18 (dp6-dp18) and dp24, corresponding to the predominantly unsulfated GlcA-GlcNAc domains of heparan sulfate. Unlike heparin, the sedimentation coefficient s(20,)(w) of HS dp6-dp24 showed a small rotor speed dependence, where similar s(20,)(w) values of 0.82-1.26 S (absorbance optics) and 1.05-1.34 S (interference optics) were determined. The corresponding x-ray scattering measurements of HS dp6-dp24 gave radius of gyration (R(G)) values from 1.03 to 2.82 nm, cross-sectional radius of gyration (R(XS)) values from 0.31 to 0.65 nm, and maximum lengths (L) from 3.0 to 10.0 nm. These data showed that HS has a longer and more bent structure than heparin. Constrained scattering modeling starting from 5000-8000 conformationally randomized HS structures gave best fit dp6-dp16 molecular structures that were longer and more bent than their equivalents in heparin. No fits were obtained for HS dp18 or dp24, indicating their higher flexibility. We conclude that HS displays an extended bent conformation that is significantly distinct from that for heparin. The difference is attributed to the different predominant monosaccharide sequence and reduced sulfation of HS, indicating that HS may interact differently with proteins compared with heparin.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21576246      PMCID: PMC3137059          DOI: 10.1074/jbc.M111.226027

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

Review 1.  Specificities of heparan sulphate proteoglycans in developmental processes.

Authors:  N Perrimon; M Bernfield
Journal:  Nature       Date:  2000-04-13       Impact factor: 49.962

Review 2.  Heparin and heparan sulfate: biosynthesis, structure and function.

Authors:  R Sasisekharan; G Venkataraman
Journal:  Curr Opin Chem Biol       Date:  2000-12       Impact factor: 8.822

Review 3.  Roles of heparan-sulphate glycosaminoglycans in cancer.

Authors:  Ram Sasisekharan; Zachary Shriver; Ganesh Venkataraman; Uma Narayanasami
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

Review 4.  Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans.

Authors:  M Bernfield; R Kokenyesi; M Kato; M T Hinkes; J Spring; R L Gallo; E J Lose
Journal:  Annu Rev Cell Biol       Date:  1992

5.  Calculating sedimentation coefficient distributions by direct modeling of sedimentation velocity concentration profiles.

Authors:  Julie Dam; Peter Schuck
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

6.  Structure and interactions of heparan sulfate proteoglycans from a mouse tumor basement membrane.

Authors:  S Fujiwara; H Wiedemann; R Timpl; A Lustig; J Engel
Journal:  Eur J Biochem       Date:  1984-08-15

7.  The 15 SCR flexible extracellular domains of human complement receptor type 2 can mediate multiple ligand and antigen interactions.

Authors:  Hannah E Gilbert; Rengasamy Asokan; V Michael Holers; Stephen J Perkins
Journal:  J Mol Biol       Date:  2006-08-09       Impact factor: 5.469

Review 8.  Conformation and dynamics of heparin and heparan sulfate.

Authors:  B Mulloy; M J Forster
Journal:  Glycobiology       Date:  2000-11       Impact factor: 4.313

9.  Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling.

Authors:  P Schuck
Journal:  Biophys J       Date:  2000-03       Impact factor: 4.033

10.  Characterization of the binding site on heparan sulfate for macrophage inflammatory protein 1alpha.

Authors:  Sally E Stringer; Mark J Forster; Barbara Mulloy; Christopher R Bishop; Gerard J Graham; John T Gallagher
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

View more
  9 in total

1.  Preparation, separation, and conformational analysis of differentially sulfated heparin octasaccharide isomers using ion mobility mass spectrometry.

Authors:  Youjin Seo; Armann Andaya; Julie A Leary
Journal:  Anal Chem       Date:  2012-02-14       Impact factor: 6.986

2.  Crystal structure of N-glycosylated human glypican-1 core protein: structure of two loops evolutionarily conserved in vertebrate glypican-1.

Authors:  Gabriel Svensson; Wael Awad; Maria Håkansson; Katrin Mani; Derek T Logan
Journal:  J Biol Chem       Date:  2012-02-20       Impact factor: 5.157

3.  Targeting of heparanase-modified syndecan-1 by prosecretory mitogen lacritin requires conserved core GAGAL plus heparan and chondroitin sulfate as a novel hybrid binding site that enhances selectivity.

Authors:  Yinghui Zhang; Ningning Wang; Ronald W Raab; Robert L McKown; Jacob A Irwin; Inchan Kwon; Toin H van Kuppevelt; Gordon W Laurie
Journal:  J Biol Chem       Date:  2013-03-15       Impact factor: 5.157

4.  Large-scale investigation of Leishmania interaction networks with host extracellular matrix by surface plasmon resonance imaging.

Authors:  Marie Fatoux-Ardore; Franck Peysselon; Anthony Weiss; Patrick Bastien; Francine Pratlong; Sylvie Ricard-Blum
Journal:  Infect Immun       Date:  2013-11-25       Impact factor: 3.441

5.  SCT: a suite of programs for comparing atomistic models with small-angle scattering data.

Authors:  David W Wright; Stephen J Perkins
Journal:  J Appl Crystallogr       Date:  2015-05-09       Impact factor: 3.304

6.  An integrated approach using orthogonal analytical techniques to characterize heparan sulfate structure.

Authors:  Daniela Beccati; Miroslaw Lech; Jennifer Ozug; Nur Sibel Gunay; Jing Wang; Elaine Y Sun; Joël R Pradines; Victor Farutin; Zachary Shriver; Ganesh V Kaundinya; Ishan Capila
Journal:  Glycoconj J       Date:  2016-10-22       Impact factor: 2.916

7.  Perlecan domain 1 recombinant proteoglycan augments BMP-2 activity and osteogenesis.

Authors:  Arthur A Decarlo; Maria Belousova; April L Ellis; Donald Petersen; Hernan Grenett; Patrick Hardigan; Robert O'Grady; Megan Lord; John M Whitelock
Journal:  BMC Biotechnol       Date:  2012-09-11       Impact factor: 2.563

8.  The solution structure of heparan sulfate differs from that of heparin: implications for function.

Authors:  Sanaullah Khan; Ka Wai Fung; Elizabeth Rodriguez; Rima Patel; Jayesh Gor; Barbara Mulloy; Stephen J Perkins
Journal:  J Biol Chem       Date:  2013-08-06       Impact factor: 5.157

Review 9.  Molecular Interactions between Complement Factor H and Its Heparin and Heparan Sulfate Ligands.

Authors:  Stephen J Perkins; Ka Wai Fung; Sanaullah Khan
Journal:  Front Immunol       Date:  2014-03-31       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.